$COUR
Coursera, Inc.

2021 Q1 Form 10-Q Financial Statement

#000095017021000180 Filed on May 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $88.36M $53.85M
YoY Change 64.1% 34.15%
Cost Of Revenue $38.83M $24.95M
YoY Change 55.61% 24.32%
Gross Profit $49.54M $28.90M
YoY Change 71.43% 43.98%
Gross Profit Margin 56.06% 53.66%
Selling, General & Admin $45.76M $27.78M
YoY Change 64.7% 55.21%
% of Gross Profit 92.37% 96.14%
Research & Development $22.14M $15.78M
YoY Change 40.28% 44.67%
% of Gross Profit 44.69% 54.62%
Depreciation & Amortization $2.931M $1.993M
YoY Change 47.06%
% of Gross Profit 5.92% 6.9%
Operating Expenses $67.90M $43.57M
YoY Change 55.85% 51.21%
Operating Profit -$18.36M -$14.67M
YoY Change 25.17% 67.84%
Interest Expense $80.00K $700.0K
YoY Change -88.57% 52.17%
% of Operating Profit
Other Income/Expense, Net -$7.000K -$252.0K
YoY Change -97.22% 740.0%
Pretax Income -$18.29M -$14.23M
YoY Change 28.56% 71.18%
Income Tax $375.0K $89.00K
% Of Pretax Income
Net Earnings -$18.66M -$14.31M
YoY Change 30.38% 71.02%
Net Earnings / Revenue -21.12% -26.58%
Basic Earnings Per Share
Diluted Earnings Per Share -$452.7K -$109.8K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $280.8M
YoY Change
Cash & Equivalents $158.1M $103.9M
Short-Term Investments $122.7M
Other Short-Term Assets $34.80M
YoY Change
Inventory
Prepaid Expenses
Receivables $35.58M
Other Receivables $0.00
Total Short-Term Assets $351.2M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $21.08M
YoY Change
Goodwill
YoY Change
Intangibles $10.31M
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.407M
YoY Change
Total Long-Term Assets $63.62M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $351.2M
Total Long-Term Assets $63.62M
Total Assets $414.8M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.40M
YoY Change
Accrued Expenses $16.30M
YoY Change
Deferred Revenue $85.25M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $157.8M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $623.0K
YoY Change
Total Long-Term Liabilities $623.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $157.8M
Total Long-Term Liabilities $623.0K
Total Liabilities $178.6M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$362.2M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.701M
YoY Change
Treasury Stock Shares $2.748M
Shareholders Equity -$226.1M -$197.7M
YoY Change
Total Liabilities & Shareholders Equity $414.8M
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$18.66M -$14.31M
YoY Change 30.38% 71.02%
Depreciation, Depletion And Amortization $2.931M $1.993M
YoY Change 47.06%
Cash From Operating Activities -$4.347M -$7.536M
YoY Change -42.32%
INVESTING ACTIVITIES
Capital Expenditures -$4.460M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $82.50M
YoY Change
Cash From Investing Activities $78.04M $55.06M
YoY Change 41.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.503M 421.0K
YoY Change 969.6%
NET CHANGE
Cash From Operating Activities -4.347M -7.536M
Cash From Investing Activities 78.04M 55.06M
Cash From Financing Activities 4.503M 421.0K
Net Change In Cash 78.19M 47.95M
YoY Change 63.08%
FREE CASH FLOW
Cash From Operating Activities -$4.347M -$7.536M
Capital Expenditures -$4.460M
Free Cash Flow $113.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001651562
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-40275
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
COURSERA, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3560292
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
381 E. Evelyn Ave.
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94041
CY2021Q1 dei City Area Code
CityAreaCode
650
CY2021Q1 dei Trading Symbol
TradingSymbol
COUR
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
963-9884
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
205402000
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135770469
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79878000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
158072000
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
122729000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
48000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
146000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40721000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35582000
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
14077000
CY2021Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
16149000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14993000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18666000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
355071000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
351198000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18644000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21080000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21622000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20276000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10570000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10313000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2548000
CY2021Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2548000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9169000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9407000
CY2020Q4 us-gaap Assets
Assets
417624000
CY2021Q1 us-gaap Assets
Assets
414822000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
39005000
CY2021Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
41360000
CY2020Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
12897000
CY2021Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
9813000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12997000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8354000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7926000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7973000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
76080000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
85254000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4739000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5052000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
153644000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18305000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16676000
CY2021Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
157806000
CY2021Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
76420805
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
76420805
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
644000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
623000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4562000
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3513000
CY2020Q4 us-gaap Liabilities
Liabilities
177155000
CY2021Q1 us-gaap Liabilities
Liabilities
178618000
CY2021Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
75305400
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
75305400
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
75305400
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
75305400
CY2021Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
464036000
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
464036000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
462293000
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
462293000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
162000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
162000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40301290
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40301290
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43193216
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43193216
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
126408000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140803000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2747938
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2747938
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4701000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
4701000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
23000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-343551000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-362214000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-221824000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-226089000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
417624000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
414822000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53847000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
88362000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
24951000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
38826000
CY2020Q1 us-gaap Gross Profit
GrossProfit
28896000
CY2021Q1 us-gaap Gross Profit
GrossProfit
49536000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15783000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22140000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20696000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32613000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7086000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13144000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
43565000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
67897000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-14669000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18361000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
696000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
80000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-252000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14225000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18288000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
89000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-14314000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-18663000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35666172
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41218355
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-14314000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18663000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-47000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14361000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18660000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-186999000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
421000
CY2020Q1 cour Adjustments To Additional Paid In Capital Vesting Of Early Exercise Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseStockOptions
75000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3170000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-47000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-14314000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-197694000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-221824000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8564000
CY2021Q1 cour Adjustments To Additional Paid In Capital Vesting Of Early Exercise Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseStockOptions
21000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5810000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18663000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-226089000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-14314000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-18663000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1993000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2931000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3014000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5284000
CY2020Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
149000
CY2021Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-177000
CY2020Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
40000
CY2021Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
98000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3414000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5041000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
909000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
260000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1264000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1345000
CY2020Q1 cour Increase Decrease In Educator Partners And Other Accounts Payable
IncreaseDecreaseInEducatorPartnersAndOtherAccountsPayable
2133000
CY2021Q1 cour Increase Decrease In Educator Partners And Other Accounts Payable
IncreaseDecreaseInEducatorPartnersAndOtherAccountsPayable
-3032000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7052000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-4330000
CY2020Q1 cour Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1368000
CY2021Q1 cour Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1582000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
9408000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8124000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7536000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4347000
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5939000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
63359000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
82500000
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
582000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
307000
CY2020Q1 cour Payments To Capitalized Internal Use Software Costs
PaymentsToCapitalizedInternalUseSoftwareCosts
1774000
CY2021Q1 cour Payments To Capitalized Internal Use Software Costs
PaymentsToCapitalizedInternalUseSoftwareCosts
3985000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
55064000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
78038000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
421000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8564000
CY2021Q1 cour Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
4061000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
421000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4503000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47949000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
78194000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59845000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82426000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107794000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160620000
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
2548000
CY2020Q1 cour Restricted Cash In Prepaid Expenses And Other Current Assets
RestrictedCashInPrepaidExpensesAndOtherCurrentAssets
769000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103935000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
158072000
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
3090000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107794000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160620000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
534000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
157000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
530000
CY2020Q1 cour Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
75000
CY2021Q1 cour Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
21000
CY2020Q1 cour Share Based Compensation Capitalized As Internal Use Software
ShareBasedCompensationCapitalizedAsInternalUseSoftware
156000
CY2021Q1 cour Share Based Compensation Capitalized As Internal Use Software
ShareBasedCompensationCapitalizedAsInternalUseSoftware
526000
CY2021Q1 cour Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
2182000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="padding-top:12.0pt;text-indent:24.5pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates, including those related to fair value of common stock and stock-based awards; period of benefit for capitalized commissions; internal-use software development costs; useful lives of long-lived assets; the carrying value of operating lease right-of-use assets; valuation of intangible assets and income tax expense, including the valuation of deferred tax assets and liabilities, among others.</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span> </span></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The World Health Organization declared in March 2020 that the recent outbreak of the coronavirus disease (“COVID-19") constitutes a pandemic. The COVID-19 pandemic has caused general business disruption worldwide beginning in January 2020. The global impact of COVID-19 continues to rapidly evolve, and the Company will continue to monitor the situation and the effects on its business and operations closely. The Company does not yet know the full extent of potential impacts on its business or operations or on the global economy as a whole, particularly if the COVID-19 pandemic continues and persists for an extended period of time. Given the uncertainty, the Company cannot reasonably estimate the impact on its future results of operations, cash flows, or financial condition. As of the date of issuance of the condensed consolidated financial statements, the Company is not aware of any specific event or circumstance that would require it to update its estimates, judgments, or the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="padding-top:12.0pt;text-indent:24.5pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentration of Credit Risk</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company invests only in high-credit-quality instruments and maintains its cash equivalents and marketable securities in fixed-income securities. The Company places its cash primarily with domestic financial institutions that are federally insured within statutory limits.</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="padding-top:12.0pt;text-indent:24.5pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer. For the three months ended March 31, 2020 and 2021, the Company did not have any customers that accounted for more than </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the Company’s revenue. As of December 31, 2020, the Company had </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customer that accounted for </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of its net accounts receivable balance. As of March 31, 2021, the Company had </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customers that accounted for more than </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of its net accounts receivable balance.</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2020Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
16592000
CY2020Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
39976000
CY2021Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
28043000
CY2020Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
64000
CY2020Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
745000
CY2021Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
7539000
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
16656000
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
40721000
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
35582000
CY2020Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
41607000
CY2020Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
80642000
CY2021Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
88767000
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41607000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
80642000
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
88767000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
19595000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
37522000
CY2020Q1 cour Impairment Losses On Contract Assets
ImpairmentLossesOnContractAssets
0
CY2021Q1 cour Impairment Losses On Contract Assets
ImpairmentLossesOnContractAssets
0
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
193918000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.63
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q1 cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
1333000
CY2021Q1 cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
2289000
CY2020Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
769000
CY2021Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1666000
CY2020Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
3026000
CY2021Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
3152000
CY2020Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
6581000
CY2021Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
6600000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
264399000
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
256326000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
205382000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
21000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
205402000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
122706000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
24000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
122729000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
205382000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
205402000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
122706000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
122729000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
20201000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
5500000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34540000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39406000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15896000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18326000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18644000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21080000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12583000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2013000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10570000
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12753000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2440000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10313000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
366000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
427000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1722000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2270000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2232000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2237000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1711000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
141000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10313000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0063
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0205
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
76420805
CY2021Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
76420805
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
75305400
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
75305400
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
462293000
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
462293000
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
464036000
CY2021Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
464036000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3014000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5284000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
58732000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M18D
CY2020Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
75305400
CY2021Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
75305400
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
32458408
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
29308725
CY2020Q4 cour Share Based Compensation Arrangement By Share Based Payment Award Options Rs Us Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRSUsOutstanding
3276600
CY2021Q1 cour Share Based Compensation Arrangement By Share Based Payment Award Options Rs Us Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRSUsOutstanding
6151271
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8098484
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
18213838
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
119138892
CY2021Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
128979234
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14314000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18663000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35666172
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41218355
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
98428111
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
110804980
CY2021Q1 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
58172000
CY2021Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
1
CY2021Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53847000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
88362000
CY2020Q1 cour Segment Gross Profit Loss
SegmentGrossProfitLoss
34741000
CY2021Q1 cour Segment Gross Profit Loss
SegmentGrossProfitLoss
58197000
CY2020Q1 cour Platform And Support Costs
PlatformAndSupportCosts
4228000
CY2021Q1 cour Platform And Support Costs
PlatformAndSupportCosts
6312000
CY2020Q1 cour Segment Share Based Compensation
SegmentShareBasedCompensation
110000
CY2021Q1 cour Segment Share Based Compensation
SegmentShareBasedCompensation
107000
CY2020Q1 cour Total Reconciliation Item Of Segment Gross Profit To Gross Profit
TotalReconciliationItemOfSegmentGrossProfitToGrossProfit
5845000
CY2021Q1 cour Total Reconciliation Item Of Segment Gross Profit To Gross Profit
TotalReconciliationItemOfSegmentGrossProfitToGrossProfit
8661000
CY2020Q1 us-gaap Gross Profit
GrossProfit
28896000
CY2021Q1 us-gaap Gross Profit
GrossProfit
49536000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53847000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
88362000
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
40266000
CY2021Q1 us-gaap Noncurrent Assets
NoncurrentAssets
41356000
CY2021Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6243000
CY2021Q2 cour Conversion Of Stock Conversion Ratio
ConversionOfStockConversionRatio
1

Files In Submission

Name View Source Status
0000950170-21-000180-index-headers.html Edgar Link pending
0000950170-21-000180-index.html Edgar Link pending
0000950170-21-000180.txt Edgar Link pending
0000950170-21-000180-xbrl.zip Edgar Link pending
cour-20210331-ex10_1.htm Edgar Link pending
cour-20210331-ex10_2.htm Edgar Link pending
cour-20210331-ex31_1.htm Edgar Link pending
cour-20210331-ex31_2.htm Edgar Link pending
cour-20210331-ex32_1.htm Edgar Link pending
cour-20210331-ex32_2.htm Edgar Link pending
cour-20210331-ex3_1.htm Edgar Link pending
cour-20210331-ex3_2.htm Edgar Link pending
cour-20210331.htm Edgar Link pending
cour-20210331.xsd Edgar Link pending
cour-20210331_cal.xml Edgar Link unprocessable
cour-20210331_def.xml Edgar Link unprocessable
cour-20210331_htm.xml Edgar Link completed
cour-20210331_lab.xml Edgar Link unprocessable
cour-20210331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending